Alcon

Alcon is a global leader in eye care with over 75 years of heritage, dedicated to enhancing sight and improving lives through innovative...

On March 26, 2025, Alcon acquired a majority interest in Aurion Biotech, Inc. to advance cell therapy for corneal endothelial disease, with Aurion's lead asset receiving Breakthrough Therapy and Regenerative Medicine Advanced Therapy Designations from the FDA...

Alcon is promoting their new Precision 1 contact lenses with free trials at optical centers in Italy...

Alcon and Lens.com settled a 7-year trademark dispute over unauthorized reselling of Alcon's products...

Alcon has introduced the UNITY® VCS/CS, a new innovation in eye surgery, receiving positive feedback from surgeons...

Alcon is currently seeking a Director, Integrity & Compliance Policy in the United States...